Skip to main content
OpenTrials

Clinical trial condition

Follicular Lymphoma (FL)

Explore clinical trials studying Follicular Lymphoma (FL). Study availability and eligibility vary by location and protocol.

25 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Follicular Lymphoma (FL) trial results

Completed

CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies

NCT04450069

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at San Diego San Diego, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Active, Not Recruiting

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma

NCT05409066

Conditions
Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • The University of Arizona Cancer Center - North Campus /ID# 228862 Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences /ID# 227198 Little Rock, Arkansas, United States
  • Alta Bates Summit Medical Center for Research /ID# 229428 Berkeley, California, United States
  • Beverly Hills Cancer Center /ID# 231535 Beverly Hills, California, United States
View all 273 locations
View Trial Details
Active, Not Recruiting

A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma

NCT05888493

Conditions
Disease Attributes, Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, +12 more
Locations
  • Novartis Investigative Site Camperdown, New South Wales, Australia
  • Novartis Investigative Site Clayton, Victoria, Australia
  • Novartis Investigative Site Melbourne, Victoria, Australia
  • Novartis Investigative Site Nedlands, Western Australia, Australia
View all 30 locations
View Trial Details
Active, Not Recruiting

A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma

NCT06097364

Conditions
Disease Attributes, Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, +12 more
Locations
  • Boca Raton Clinical Research (BRCR) Global Plantation, Florida, United States
  • Investigative Clinical Research of Indiana Noblesville, Indiana, United States
  • Cancer Center of Kansas Wichita, Kansas, United States
  • University of Kentucky Lexington, Kentucky, United States
View all 145 locations
View Trial Details

Related conditions